Sign in
Taking peopleNo phase

Immune cells in the womb lining and blood of women with fertility problems

Compares immune cells in womb lining and blood of women with infertility or miscarriages.

Key facts

Who runs it
Jagiellonian University
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Immune Cell Populations in the Endometrium
Status
Recruiting
People taking part
50 people, planned
Started
1 Jul 2025
Planned end
30 Jun 2026
Type of study
Observational, 2 groups
Treatments tested
  • Percentage distribution of immune system cells in peripheral blood
  • Percentage distribution of immune system cells in endometrium
Record updated
19 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with unexplained infertility or at least 2 miscarriages, and fertile women for comparison. It studies immune cells in the blood and the lining of the womb.

Age
18 to 45 years
Sex
Women only
Disease stage
Unexplained (idiopathic) infertility, at least 2 miscarriages, or other non-cancerous gynecological conditions where a sample of the womb lining is taken. A comparison group of women with a past normal pregnancy conceived naturally.
Earlier treatment
No antibiotic treatment within the last 3 months.

Main reasons for not taking part

  • Miscarriage within the last 3 months
  • Abdominal or womb surgery within the last 3 months
  • Viral or bacterial infection within the last 3 months
  • Antibiotic treatment within the last 3 months

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • age 18-45 years
  • idiopathic infertility
  • at least 2 miscarriages
  • other benign gynecological conditions subjected to endometrial sampling

Who cannot take part

  • abdominal/uterine surgery within last 3 months
  • antibiotic therapy within last 3 months
  • viral/bacterial infection within last 3 months
  • miscarriage within last 3 months

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

This trial is currently available in Poland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Specialized immunological studies in the diagnostics of idiopathic infertility and recurrent miscarriages have limited applicability, as the role of the immune system in these conditions is not thoroughly understood. In ovulatory cycles, changes occur in the populations of uterine lymphocytes, which may influence the receptivity of the endometrium and the implantation of the embryo. Particularly notable are the changes in natural killer (NK) cells, which reach their peak during the luteal phase and regulate the invasion of the trophoblast. The dominant NK cells exhibit a CD56bright phenotype and differ in cytokine profiles from peripheral blood cells. Cyclical changes also affect macrophages and T lymphocytes; however, it is unclear whether their proportions differ in women with reduced fertility. There is a need to investigate how the composition of lymphocytes in blood influences the populations in the endometrium. The aim of this study is to analyze the correlation between peripheral and endometrial lymphocytes in women with idiopathic infertility and recurrent miscarriages, compared to fertile women.

The 2 groups in the trial

  • Infertility

    Women aged 18-45 with idiopathic infertility/recurrent miscarriages

    Treatment: Percentage distribution of immune system cells in peripheral blood and Percentage distribution of immune system cells in endometrium

  • Normal fertility

    Women aged 18-45 with a history of normal pregnancy obtained by spontaneous fertilization

    Treatment: Percentage distribution of immune system cells in peripheral blood and Percentage distribution of immune system cells in endometrium

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Analysis of Immune Cell Populations in the Endometrium and Peripheral Blood in Women With Reduced and Normal Fertility
Plain-language title
Immune cells in the womb lining and blood of women with fertility problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06826365, who can take part
Record updated
19 March 2026